# Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

> **NCT00411580** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 58 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** CAD106
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00411580
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2013-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411580, "Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00411580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*